Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:35:03 EDT Tue 23 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:APDN from 2023-04-24 to 2024-04-23 - 24 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-22 16:07U:APDNNews ReleaseApplied DNA Announces 1-For-20 Reverse Stock Split
2024-03-18 09:02U:APDNNews ReleaseApplied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
2024-03-14 10:02U:APDNNews ReleaseApplied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
2024-02-08 16:08U:APDNNews ReleaseApplied DNA Announces First Quarter Fiscal Year 2024 Financial Results
2024-02-05 13:02U:APDNNews ReleaseApplied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
2024-02-02 16:18U:APDNNews ReleaseApplied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2024-01-31 08:01U:APDNNews ReleaseApplied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2023-12-14 08:01U:APDNNews ReleaseApplied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology ¢ € ™s mRNA Manufacturing Workflow
2023-12-07 16:10U:APDNNews ReleaseApplied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
2023-12-05 08:32U:APDNNews ReleaseApplied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
2023-11-28 08:32U:APDNNews ReleaseApplied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
2023-11-16 08:31U:APDNNews ReleaseApplied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
2023-11-09 09:16U:APDNNews ReleaseApplied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
2023-09-14 09:04U:APDNNews ReleaseApplied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
2023-09-06 09:02U:APDNNews ReleaseApplied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
2023-08-29 09:02U:APDNNews ReleaseApplied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit
2023-08-23 09:33U:APDNNews ReleaseApplied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production
2023-08-10 16:08U:APDNNews ReleaseApplied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
2023-08-07 11:03U:APDNNews ReleaseApplied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023
2023-07-18 10:01U:APDNNews ReleaseApplied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
2023-07-13 07:17U:APDNNews ReleaseApplied DNA Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT(TM) Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach
2023-06-08 11:02U:APDNNews ReleaseApplied DNA Announces Presentation at Upcoming Healthcare Investor Conference
2023-05-11 16:06U:APDNNews ReleaseApplied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
2023-05-03 15:00U:APDNNews ReleaseApplied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023